Pilot study of the efficacy of atevirdine in the treatment of AIDS dementia complex

AIDS

Volumn 10, Issue 12, 1996, Pages 1357-1360

  Brew, Bruce J ^a,c   Dunbar, Nicola ^a   Druett, Julie Anne ^a   Freund, Judith ^a   Ward, Penelope ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b Pharmacia and Upjohn   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

AIDS; Atevirdine; Dementia; Therapy

Indexed keywords

ATEVIRDINE; CD4 ANTIGEN; DIDANOSINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANXIETY; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; DEMENTIA; DIARRHEA; FATIGUE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROPSYCHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RASH; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0029743499     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199610000-00007     Document Type: Article

References (11)

1. Schmitt FA, Bigley JW, McKinnis R, et al.: Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS related complex. N Engl J Med 1988, 319:1573- 1578.
2. Sidtis JJ, Gatsonis C, Price RW, et al.: Zidovudine treatment of the AIDS dementia complex: results of a placebo controlled trial. Ann Neurol 1993, 33:343-349.
3. Butler KM, Husson RN, Balis FM, et al.: Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med 1991, 324:137-144.
4. Portegies P, Enting RH, Derix MMA, et al.: AIDS dementia complex and peripheral neuropathy in zidovudine-intolerant HIV-infected patients treated with didanosine (ddl) [abstract]. Clin Neuropathol 1993, 12 (suppl 1):S18.
5. Romero DL, Busso M, Tan C-K, et al.: Novel non-nucleoside reverse transcriptase inhibitors which potently and specifically block HIV-1 replication. Proc Natl Acad Sci USA 1991, 88:8806-8810.
6. Maio SM, Voorman RL: Distribution of U87201E to Brain Following Oral Administration in Rats (Protocol 91-004) [Upjohn Technical Report 7256-91-049 August 23 1991]. Kalamazoo: Upjohn Laboratories; 1991.
7. Nottet HSLM, Oteman MHT, Visser MR, Verhoet J: Anti-human immunodeficiency virus type 1 activity of U90152, a novel non-nucleoside, in comparison with U87201 and zidovudine against zidovudine-sensitive and zidovudine-resistant isolates in peripheral blood mononuclear cells. J Antimicrob Chemother 1994, 33:366-368.
8. Price RW, Sidtis JJ: Evaluation of the AIDS dementia complex in clinical trials. J Aquir Immune Defic Syndr 1990, 3 (suppl 2):S51-S60.
9. Richman D, Shih C-K, Lowy I, et al.: Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc Natl Acad Sci USA 1991, 88:11241-11245.
10. 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment. AIDS 1992, 6:461-465.
11. Brew BJ, Bhalla RV, Paul M, et al.: CSF neopterin in HIV-1 infection. Ann Neurol 1990, 28:556-560.